From: Triple negative breast carcinoma is a prognostic factor in Taiwanese women
Features | DFS | Overall Survival | ||||
---|---|---|---|---|---|---|
 | HR | 95% CI | p-Value | HR | 95% CI | p-Value |
Age | 1.00 | 0.99–1.01 | 0.9859 | 1.03 | 1.01–1.04 | 0.0018 |
Menopausal status | Â | Â | Â | Â | Â | Â |
   (Postmenopausal vs. Premenopausal) | 1.04 | 0.76–1.42 | 0.8132 | 1.51 | 0.98–2.33 | 0.0623 |
Tumor size, cm | 1.22 | 1.16–1.29 | <0.0001 | 1.20 | 1.11–1.31 | <0.0001 |
Lymph node | Â | Â | Â | Â | Â | Â |
   (Positive vs. Negative) | 3.08 | 2.14–4.42 | <0.0001 | 2.83 | 1.71–4.68 | <0.0001 |
Metastasis | Â | Â | Â | Â | Â | Â |
   (Yes vs. No) | 4.25 | 2.22–8.11 | <0.0001 | 9.40 | 4.78–18.49 | <0.0001 |
Grade | Â | Â | Â | Â | Â | Â |
   (III vs. I ~II) | 1.71 | 1.23–2.38 | 0.0014 | 2.03 | 1.31–3.16 | 0.0017 |
Stage | Â | Â | Â | Â | Â | Â |
   (≥ II vs. < II) | 3.03 | 1.87–4.94 | <0.0001 | 2.53 | 1.33–4.84 | 0.0048 |
ER status | Â | Â | Â | Â | Â | Â |
   (Negative vs. Positive) | 2.26 | 1.64–3.12 | <0.0001 | 3.08 | 1.98–4.79 | <0.0001 |
PgR status | Â | Â | Â | Â | Â | Â |
   (Negative vs. Positive) | 1.95 | 1.40–2.70 | <0.0001 | 2.35 | 1.50–3.68 | 0.0002 |
HER2 overexpression status | Â | Â | Â | Â | Â | Â |
   (Negative vs. Positive) | 1.97 | 1.41–2.75 | <0.0001 | 1.56 | 0.99–2.46 | 0.058 |
Tumor subgroups | Â | Â | Â | Â | Â | Â |
   (TNBC vs. non-TNBC) | 1.43 | 0.99–2.06 | 0.0570 | 1.99 | 1.26–3.13 | 0.0031 |